Placebo | Etoricoxib 10/30/60 mg | Etoricoxib 90 mg | |
---|---|---|---|
Screening/Baseline | Screening/Baseline | Screening/Baseline | |
Pain VAS | |||
Neither | 42.8/73.4 | 39.8/69.0* | 37.22/70.6 |
bDMARD | 40.2/71.2 | 39.7/69.4 | 36.17/67.8 |
CS | 38.9/73.1 | 42.2/74.9 | 38.23/72.6 |
Both | 40.1/69.9 | 42.7/71.5 | 48.50 / 73.8 |
66-SJC | |||
Neither | 8.1/16.2 | 7.3/16.6 | 7.41/15.8 |
bDMARD | 9.8/16.9 | 10.1/15.3 | 10.17/19.1 |
CS | 7.9/15.5 | 8.9/19.8 | 7.19 / 14.5 |
Both | 10.2/16.6 | 11.9/17.2 | 9.63/18.9 |
68-TJC | |||
Neither | 13.7/26.5 | 13.0/26.4 | 13.86/25.8 |
bDMARD | 12.1/29.6 | 16.8/31.9 | 15.86/28.9 |
CS | 12.5/26.2 | 12.8/26.8 | 14.25/25.4 |
Both | 13.8/29.1 | 14.2/29.6 | 12.81/28.8 |
HAQ-score | |||
Neither | 0.99/1.32 | 0.89/1.18 | 0.89/1.14 |
bDMARD | 0.86/1.32 | 1.12/1.45 | 1.01/1.35 |
CS | 1.00/1.28 | 1.02/1.42 | 0.97/1.26 |
Both | 1.57/1.67 | 1.10/1.43** | 1.45/1.64 |